Team McCallum

R&D for Lifetime of Life

Omega-3 v heart failure.

93 patients with a particular from of early stage heart failure (non-ischemic cardiomyopathy) were randomised to 850mg/day of DHA (or EPA) or to a placebo, in addition to receiving standard medical care for the condition. The patients were extensively tested over 12 months.

In the placebo group, heart function declined slightly, while it improved in the omega-3 group.

In addition, in the omega-3 group heart inflammation markers decreased, exercise capability increased, and hospitalisation rates decreased.

The work builds on an Italian study reported in 2008 showing omega-3 improved outcomes in all types of chronic heart failure.

The current results were presented at a meeting of the Heart Failure Society of America.


September 18, 2010 - Posted by | Health, Heart failure, Omega-3, Success

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: